Article
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants.
PloS one - 1 Jan 2015
Maggi Maristella, Chiarelli Laurent R, Valentini Giovanna, Scotti Claudia
Abstract excerpt
Bacterial L-asparaginases have been used as anti-cancer drugs for over 4 decades though presenting, along with their therapeutic efficacy, several side effects due to their bacterial origin and, seemingly, to their secondary glutaminase activity. Helicobacter pylori type II L-asparaginase possesses interesting features, among which a reduced catalytic efficiency for L-GLN, compared to the drugs presently used in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
